The stock price of Evolent Health Inc. (NYSE: EVH) has plunged by -5.80 when compared to previous closing price of 30.88, but the company has seen a -11.85% decline in its stock price over the last five trading sessions.
Is It Worth Investing in Evolent Health Inc. (NYSE: EVH) Right Now?
The 36-month beta value for EVH is also noteworthy at 1.54.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
The public float for EVH is 93.07M, and at present, short sellers hold a 6.22% of that float. The average trading volume of EVH on May 26, 2023 was 930.44K shares.
EVH’s Market Performance
The stock of Evolent Health Inc. (EVH) has seen a -11.85% decrease in the past week, with a -17.40% drop in the past month, and a -16.67% fall in the past quarter. The volatility ratio for the week is 4.24%, and the volatility levels for the past 30 days are at 3.76% for EVH. The simple moving average for the past 20 days is -15.22% for EVH’s stock, with a -9.27% simple moving average for the past 200 days.
EVH Trading at -12.35% from the 50-Day Moving Average
After a stumble in the market that brought EVH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.87% of loss for the given period.
Volatility was left at 3.76%, however, over the last 30 days, the volatility rate increased by 4.24%, as shares sank -18.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.96% lower at present.
During the last 5 trading sessions, EVH fell by -11.85%, which changed the moving average for the period of 200-days by -17.24% in comparison to the 20-day moving average, which settled at $33.97. In addition, Evolent Health Inc. saw 3.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EVH starting from WILLIAMS FRANK J, who sale 110,000 shares at the price of $36.29 back on May 01. After this action, WILLIAMS FRANK J now owns 819,812 shares of Evolent Health Inc., valued at $3,991,900 using the latest closing price.
WILLIAMS FRANK J, the Director of Evolent Health Inc., sale 110,000 shares at $31.83 during a trade that took place back on Apr 03, which means that WILLIAMS FRANK J is holding 819,812 shares at $3,501,348 based on the most recent closing price.
Stock Fundamentals for EVH
Current profitability levels for the company are sitting at:
- +0.37 for the present operating margin
- +18.22 for the gross margin
The net margin for Evolent Health Inc. stands at -1.38. The total capital return value is set at 0.44, while invested capital returns managed to touch -1.63. Equity return is now at value -4.60, with -2.10 for asset returns.
Based on Evolent Health Inc. (EVH), the company’s capital structure generated 55.40 points at debt to equity in total, while total debt to capital is 35.65. Total debt to assets is 26.20, with long-term debt to equity ratio resting at 54.57. Finally, the long-term debt to capital ratio is 35.12.
When we switch over and look at the enterprise to sales, we see a ratio of 2.53, with the company’s debt to enterprise value settled at 0.16. The receivables turnover for the company is 7.02 and the total asset turnover is 0.84. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
In summary, Evolent Health Inc. (EVH) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
